ADT-101

N/A

Report date: 2023/05/23 16:47:24

Base Information

Drug NameADT-101
Drug Alias NameADT-101
ClassificationOther
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsSubstance-Related DisordersObesityPrader-Willi Syndrome
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesAardvark Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesAardvark Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsSubstance-Related DisordersObesityPrader-Willi Syndrome
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A